Inhibikase Therapeutics
IKT
IKT
12 hedge funds and large institutions have $444K invested in Inhibikase Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$49.9K | |
| 2 | +$36K | |
| 3 | +$7.09K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.41K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$13 |
Top Sellers
| 1 | -$144K | |
| 2 | -$6.95K | |
| 3 | -$6.62K | |
| 4 |
Morgan Stanley
New York
|
-$3.68K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |